14.05.2013 Views

Book of Medical Disorders in Pregnancy - Tintash

Book of Medical Disorders in Pregnancy - Tintash

Book of Medical Disorders in Pregnancy - Tintash

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

generally useless because the patient is<br />

usually not deficient <strong>in</strong> iron.<br />

Management options:<br />

Thrombocytopenia:<br />

Gestational:<br />

Exclude pathological causes, Monitor<br />

platelet count, No specific management<br />

if >100 *10’/1 if rapid fall or count<br />

below 50*10’/1 reevaluate for<br />

pathological causes, cord blood at<br />

delivery and ensure maternal count<br />

returns to normal<br />

Autoimmune thrombocytopenia<br />

(AITP) Pre pregnancy:<br />

Optimize management, consider splenectomy.<br />

If all therapy fails counsel<br />

regard<strong>in</strong>g risks <strong>in</strong> pregnancy<br />

Prenatal:<br />

Serial platelet counts. Treat if platelet<br />

count 50*10’/1. For delivery<br />

options for treatment. Steroids IVlg.<br />

Splenectomy Azathiopr<strong>in</strong>e if all else<br />

fails<br />

Labor and delivery:<br />

Avoid traumatic delivery, fetal scalp<br />

electrodes and Fetal scalp blood<br />

sampl<strong>in</strong>g, platelets available if count<br />

80*109/1 prompt per<strong>in</strong>eal repair.<br />

Postnatal: Cord blood for fetal platelet<br />

evaluation pediatrician at delivery,<br />

consider daily neonatal FBC if<br />

thrombocytopenic (nadir day 2-5).<br />

16<br />

Secondary Autoimmune:<br />

Thrombocytopenia: Antiphospholipid<br />

syndrome/systemic lupus erythematosus<br />

Manage thrombocytopenia as for AITP<br />

Screen<strong>in</strong>g, diagnosis and management <strong>of</strong><br />

other complications HIV thrombocytopenia,<br />

platelet counts improved by IVIg,<br />

Zidovud<strong>in</strong>e, and corticosteroids.<br />

(But secondary <strong>in</strong>fection risk), cesarean<br />

section will need to be covered by IV<br />

Platelets if refractory thrombocytopenia<br />

Drug-<strong>in</strong>duced thrombocytopenia stop<br />

drug and choose alternative. Alternatives<br />

for hepar<strong>in</strong>-<strong>in</strong>duced thrombocytopenia<br />

<strong>in</strong>clude danaparoid.<br />

Non-immune platelet consumption:<br />

Dissem<strong>in</strong>ated <strong>in</strong>travascular coagulation,<br />

Preeclampsia/HELLP.<br />

Thrombotic thrombocytopenic:<br />

purpura:<br />

Plasma exchange is first l<strong>in</strong>e treatment<br />

fresh frozen plasma <strong>in</strong>fusion is second<br />

l<strong>in</strong>e treatment. Avoid platelet transfusion<br />

Management options acute leukemia:<br />

Hematological malignancies:<br />

Pre pregnancy:<br />

Counsel about prognosis, Advise aga<strong>in</strong>st<br />

conception until <strong>in</strong> remission and not on<br />

chemotherapy.<br />

Prenatal: Start chemotherapy as for non<br />

pregnant supportive therapy (blood,<br />

platelets, antibiotics, etc.). Careful<br />

counsel<strong>in</strong>g, especially if treatment<br />

commenced <strong>in</strong> first trimester. Monitor<br />

fetal growth and health.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!